* Pharvaris NV PHVS.OQ reported a quarterly adjusted loss
of 39 cents per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 45 cents per share.
* Reported revenue was zero; analysts expected zero.
* Pharvaris NV's reported EPS for the quarter was a loss of 39
cents.
* The mean earnings estimate of analysts was unchanged in the
last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Pharvaris NV shares had fallen by 9.6% this quarter.
* The company reported a quarterly loss of €9.1 million.
* Wall Street's median 12-month price target for Pharvaris NV is
$48.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated November 10 at 03:15 p.m.
All figures in euros unless otherwise stated